AKR1C1 Protects Corneal Epithelial Cells Against Oxidative Stress-Mediated Ferroptosis in Dry Eye

Xin Zuo1, Hao Zeng1, Bowen Wang1

  • 1State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou, China.

Abstract

Insights

Dry eye disease (DED) involves cell death via ferroptosis, driven by oxidative stress. Upregulating AKR1C1, activated by NRF2, protects against this damage and inflammation, offering therapeutic targets for DED.

Area of Science:

  • Ophthalmology
  • Cell Biology
  • Molecular Medicine

Background:

  • Dry eye disease (DED) is a prevalent ocular surface condition characterized by inflammation and cell death.
  • The precise mechanisms driving cell death and inflammation in DED require further elucidation.

Purpose of the Study:

  • To determine the mode of cell death in DED.
  • To investigate the molecular pathways initiating inflammation in DED.

Main Methods:

  • Established a DED mouse model using scopolamine and desiccating stress.
  • Utilized human corneal epithelial cells (HCECs) cultured under hyperosmolarity.
  • Assessed protein and mRNA expression, intracellular iron, reactive oxygen species, and lipid peroxidation.

Main Results:

  • Observed ferroptosis markers, iron accumulation, and lipid peroxidation in DED corneal cells.
  • Suppression of oxidative stress reduced ferroptosis in HCECs.
  • AKR1C1 upregulation by NRF2 mitigated ferroptosis and inflammation; AKR1C1 inhibition exacerbated DED phenotypes in vivo.

Conclusions:

  • Ferroptosis, induced by oxidative stress, contributes to DED pathogenesis.
  • NRF2-activated AKR1C1 protects against ferroptosis-induced damage and inflammation in corneal epithelial cells.
  • Targeting ferroptosis and AKR1C1 presents potential therapeutic strategies for DED.

Related Concept Videos